In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Jazz Pharmaceuticals PLC

www.jazzpharma.com

Latest From Jazz Pharmaceuticals PLC

ImmunoGen Needs Another Phase III For Its ADC In Ovarian Cancer

The biotech’s hopes for an accelerated approval on subgroup data were dashed by the US FDA, but it will work with the agency to design a Phase III focused on highly FRα-positive patients.

Clinical Trials Drug Approval Standards

Start-Up Quarterly Statistics: Anthos, Gossamer Lead Q1 Financings; Codiak/Jazz Deal Tops Alliances

In a review of biopharma start-up dealmaking and financing activity from January through March, based on data from Strategic Transactions, Anthos completed the largest venture capital round in the first quarter, raising $250m.

Deals Financing

IPO Update: Pace Of US Offerings Slows As 13 Biopharmas Go Public In 2019

With about three IPOs per month compared with a pace of nearly six per month in 2018, drug developers have raised $1.55bn with US offerings this year – though returns have been mixed.

Financing Business Strategies

Amgen, Astellas Bring Tally Of US Charity Co-Pay Kickback Settlements To Eight

Astellas to pay $100m and Amgen to pay $24.75m to resolve allegations they paid Medicare copays for their products through copay assistance foundations.

Legal Issues Enforcement
See All

Company Information

  • Industry
  • Pharmaceuticals
    • Drug Delivery
      • Nasal
    • Specialty Pharmaceuticals
  • Therapeutic Areas
  • Blood & Coagulation Disorders & Products
  • Cancer
  • Hepatic (Liver)
  • Neurology, Nervous System
  • Alias(es)
  • Jazz Pharmaceuticals Inc.
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • Ireland
  • Parent & Subsidiaries
  • Jazz Pharmaceuticals PLC
  • Senior Management
  • Bruce C Cozadd, Chmn. & CEO
    Matthew Young, EVP, CFO
    Daniel N Swisher, Jr., Pres. & COO
  • Contact Info
  • Jazz Pharmaceuticals PLC
    Phone: 1 634 7800
    Waterloo Exchange
    Waterloo Rd.
    Dublin 4, CA
    Ireland
Advertisement
Advertisement
UsernamePublicRestriction

Register